Novartis Influenza Vaccine B
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Novartis Influenza Vaccine B, covering 2017-04-21 to 2017-04-21. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Safety of Two Influenza Vaccines in Children and Adolescents 3 to <18 Years of Age at Risk for Influenza-Related Complications [Phase 3]